Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 19

1.

Complement C5-inhibiting therapy for the thrombotic microangiopathies: accumulating evidence, but not a panacea.

Brocklebank V, Kavanagh D.

Clin Kidney J. 2017 Oct;10(5):600-624. doi: 10.1093/ckj/sfx081. Epub 2017 May 8.

2.

The Evolving Landscape for Complement Therapeutics in Rheumatic and Autoimmune Diseases.

Thurman JM, Frazer-Abel A, Holers VM.

Arthritis Rheumatol. 2017 Nov;69(11):2102-2113. doi: 10.1002/art.40219. Epub 2017 Oct 17. Review.

PMID:
28732131
3.

Emerging Treatment Models in Rheumatology: Antiphospholipid Syndrome and Pregnancy: Pathogenesis to Translation.

Abrahams VM, Chamley LW, Salmon JE.

Arthritis Rheumatol. 2017 Sep;69(9):1710-1721. doi: 10.1002/art.40136. Epub 2017 Jul 18. Review. No abstract available.

PMID:
28445926
4.

Recent advances in understanding antiphospholipid syndrome.

Bertolaccini ML, Sanna G.

F1000Res. 2016 Dec 22;5:2908. doi: 10.12688/f1000research.9717.1. eCollection 2016. Review.

5.

Circulating Immune Complexes of IgA Bound to Beta 2 Glycoprotein are Strongly Associated with the Occurrence of Acute Thrombotic Events.

Martínez-Flores JA, Serrano M, Pérez D, Cámara A G, Lora D, Morillas L, Ayala R, Paz-Artal E, Morales JM, Serrano A.

J Atheroscler Thromb. 2016 Oct 1;23(10):1242-1253. Epub 2016 Apr 11.

6.

Early Components of the Complement Classical Activation Pathway in Human Systemic Autoimmune Diseases.

Lintner KE, Wu YL, Yang Y, Spencer CH, Hauptmann G, Hebert LA, Atkinson JP, Yu CY.

Front Immunol. 2016 Feb 15;7:36. doi: 10.3389/fimmu.2016.00036. eCollection 2016. Review.

7.

The Pathogenicity of Anti-β2GP1-IgG Autoantibodies Depends on Fc Glycosylation.

Fickentscher C, Magorivska I, Janko C, Biermann M, Bilyy R, Nalli C, Tincani A, Medeghini V, Meini A, Nimmerjahn F, Schett G, Muñoz LE, Andreoli L, Herrmann M.

J Immunol Res. 2015;2015:638129. doi: 10.1155/2015/638129. Epub 2015 Jun 22.

8.

Evasion and interactions of the humoral innate immune response in pathogen invasion, autoimmune disease, and cancer.

Rettig TA, Harbin JN, Harrington A, Dohmen L, Fleming SD.

Clin Immunol. 2015 Oct;160(2):244-54. doi: 10.1016/j.clim.2015.06.012. Epub 2015 Jul 2. Review.

9.

Pathophysiology of the antiphospholipid antibody syndrome.

Willis R, Pierangeli SS.

Auto Immun Highlights. 2011 Mar 24;2(2):35-52. doi: 10.1007/s13317-011-0017-9. eCollection 2011 Nov. Review.

10.

CD8+DR+ T-Cells and C3 Complement Serum Concentration as Potential Biomarkers in Thrombotic Antiphospholipid Syndrome.

Sarmiento E, Dale J, Arraya M, Gallego A, Lanio N, Navarro J, Carbone J.

Autoimmune Dis. 2014;2014:868652. doi: 10.1155/2014/868652. Epub 2014 May 29.

11.

Spontaneous abortion is associated with elevated systemic C5a and reduced mRNA of complement inhibitory proteins in placenta.

Banadakoppa M, Chauhan MS, Havemann D, Balakrishnan M, Dominic JS, Yallampalli C.

Clin Exp Immunol. 2014 Sep;177(3):743-9. doi: 10.1111/cei.12371.

12.

To drive or be driven: the path of a mouse model of recurrent pregnancy loss.

Bonney EA, Brown SA.

Reproduction. 2014 Apr 8;147(5):R153-67. doi: 10.1530/REP-13-0583. Print 2014 May. Review.

13.

New insights into mechanisms behind miscarriage.

Larsen EC, Christiansen OB, Kolte AM, Macklon N.

BMC Med. 2013 Jun 26;11:154. doi: 10.1186/1741-7015-11-154. Review.

14.

Pathophysiological mechanisms in antiphospholipid syndrome.

Harper BE, Wills R, Pierangeli SS.

Int J Clin Rheumtol. 2011 Apr 1;6(2):157-171.

15.

C6 knock-out mice are protected from thrombophilia mediated by antiphospholipid antibodies.

Carrera-Marín A, Romay-Penabad Z, Papalardo E, Reyes-Maldonado E, García-Latorre E, Vargas G, Shilagard T, Pierangeli S.

Lupus. 2012 Dec;21(14):1497-505. doi: 10.1177/0961203312458839. Epub 2012 Aug 29.

16.

C5a and its receptors in human anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis.

Yuan J, Gou SJ, Huang J, Hao J, Chen M, Zhao MH.

Arthritis Res Ther. 2012 Jun 12;14(3):R140. doi: 10.1186/ar3873.

17.

Clinicopathologic correlations of renal microthrombosis and inflammatory markers in proliferative lupus nephritis.

Gonzalo E, Toldos O, Martínez-Vidal MP, Ordoñez MC, Santiago B, Fernández-Nebro A, Loza E, García I, León M, Pablos JL, Galindo M.

Arthritis Res Ther. 2012 May 28;14(3):R126. doi: 10.1186/ar3856.

18.

Effects of polyclonal IgG derived from patients with different clinical types of the antiphospholipid syndrome on monocyte signaling pathways.

Lambrianides A, Carroll CJ, Pierangeli SS, Pericleous C, Branch W, Rice J, Latchman DS, Townsend P, Isenberg DA, Rahman A, Giles IP.

J Immunol. 2010 Jun 15;184(12):6622-8. doi: 10.4049/jimmunol.0902765. Epub 2010 May 17.

19.

Antiphospholipid syndrome.

Espinosa G, Cervera R.

Arthritis Res Ther. 2008;10(6):230. doi: 10.1186/ar2536. Epub 2008 Dec 15. Review.

Supplemental Content

Support Center